On June 6, 2025, Qiqihar City held the 2025 Model Worker and May Day Labor Award Commendation Meeting. Mr. Wang Qiju, General Manager of Heilongjiang Subsidiary of Shanghai Chuanjikang Pharmaceutical Technology Co., Ltd. was awarded the honorary title of “Qiqihar Model Worker”. This award is not only a recognition of his excellent management ability, but also highlights the great importance that the municipal government attaches to Tsuenjikang's plant-based hollow capsule project and its full recognition of the company's innovative achievements in the field of plant-based pharmaceutical auxiliary materials.

As a key practitioner of Tsuenjikang's national strategic layout, Comrade Wang Qiju led the team to overcome difficulties and efficiently promote the construction of the plant-based hollow capsule production base. The project is expected to be put into production by the end of 2025, which will be an important milestone in the company's national strategic layout. Comrade Wang Qiju's award is not only a personal honor, but also the crystallization of the team's concerted efforts and common struggle.

TsuenJikang has always adhered to the mission of “promoting drug safety and safeguarding human health”, focusing on the research and development of plant-based hollow capsules and the transformation of the modernization project of traditional Chinese medicine, building a whole chain of innovation system covering raw material breeding and cultivation, process optimization to industrialization and application, and realizing the integrated development of three farmers. Its self-developed plant-based pharmaceutical excipients solutions not only fill the technical gaps of domestic plant-based hollow capsules, but also set up a technical benchmark for Chinese brands in the global plant-based pharmaceutical excipients segment.

This commendation has greatly boosted the morale of all Tsuenjikang people. In the future, the company will take the spirit of the model worker as a guide, accelerate the double-wheel drive strategy of “plant-based pharmaceutical excipients R&D center” and “Chinese medicine modernization industrial base”, inject green kinetic energy into the pharmaceutical and healthcare industry through continuous technological innovation, and export the sustainable development solutions of China's smart manufacturing to the world. The company has been promoting the two-wheel drive strategy of “Plant-based Medicine Auxiliary Materials R&D Center” and “Chinese Medicine Modernization Industrial Base”.